CFDE Data Portal | Search PMP2

	Label	Description
	PMP2 Gene (Entity type)	ENSG00000147588 - peripheral myelin protein 2
	PMP2 associations Collection (Entity type)	Associations for PMP2_associations
	PMP2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PMP2 YEAST Protein (Entity type)	Plasma membrane ATPase proteolipid 2 (precursor)
	GSE208634 1 V 2 DOXYCYCLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 trametinib NF1 8 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 10 V 6 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE137325 2 V 0 COPANLISIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

PMP2

ENSG00000147588 - peripheral myelin protein 2

PMP2 associations

Associations for PMP2_associations

PMP2 associations.tsv

A file from IDG as part of the Harmonizome project

PMP2 YEAST

Plasma membrane ATPase proteolipid 2 (precursor)

GSE208634 1 V 2 DOXYCYCLINE HUMAN DN

A Gene Set from LINCS

GSE261563 CX-5461 6 v 1 human up

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up

A Gene Set from LINCS

GSE213588 trametinib NF1 8 v 11 human dn

A Gene Set from LINCS

GSE213588 10 V 6 TRAMETINIB HUMAN DN

A Gene Set from LINCS

GSE137325 2 V 0 COPANLISIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.